Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus

Pediatr Res. 2019 Jul;86(1):12-14. doi: 10.1038/s41390-019-0344-5. Epub 2019 Feb 19.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products / therapeutic use
  • Birth Weight
  • Consensus
  • Continuous Positive Airway Pressure
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Lung Injury / physiopathology
  • Neonatology / standards*
  • Oxygen / metabolism
  • Oxygen / therapeutic use
  • Phospholipids / therapeutic use
  • Randomized Controlled Trials as Topic
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Surface-Active Agents / therapeutic use*
  • United Kingdom

Substances

  • Biological Products
  • Phospholipids
  • Surface-Active Agents
  • poractant alfa
  • Oxygen